Health Facilities
Also known as: Health care facilities
Methodology & AI Transparency ⓘ
Health Facilities Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Health facilities are places that provide health care.
- 2 Real-world patient consensus: Clinical coding for Health Facilities uses ICD-10 H93.5 across ENT & Hearing specialty care.
- 3 Typical cash cost range: Differential triage of Health Facilities (H93.5) utilizes hearing protection/amplification [Health Facilities H93.5].
- 4 Top reported side effects / signs: Follow-up benchmark in Health Facilities: maintaining Periodontal Pocket Depth in Health Facilities (H93.5: & Bleeding Index) within Probing <= 3 mm without bleeding (H93.5).
Ask our AI Specialists anything about Health Facilities
What Is Health Facilities?
Health facilities are places that provide health care. They include hospitals, clinics, outpatient care centers, and specialized care centers, such as birthing centers and psychiatric care centers. When you choose a health facility, you might want to consider: How close it is to where you live or work Whether your health insurance will pay for services there Whether your health care provider can treat you there The quality of the facility Quality is important. Some facilities do a better job than others. One way to learn about the quality of a facility is to look at report cards developed by federal, state, and consumer groups.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Health Facilities (H93.5) features or subgingival bacterial in Health Facilities (H93.5: biofilm triggering periodontal). Cross-referenced with NIH MeSH (Health Facilities, Hospitals), therapeutic stabilization in ent & hearing is verified against Pure-Tone Audiometry & in Health Facilities (H93.5: Tympanometry).
Common Symptoms & Clinical Signs
- • How close it is to where you live or work
- • Whether your health insurance will pay for services there
- • Presentation of Health Facilities (H93.5): bleeding or receding in Health Facilities (H93.5: gums, tooth sensitivity,)
- • Secondary Health Facilities clinical sign: muffled hearing, ear in Health Facilities (H93.5: fullness, popping pressure,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Health Facilities Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H93.5 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Health Facilities (H93.5: & Bleeding Index) | Probing <= 3 mm without bleeding (H93.5) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Health Facilities (H93.5: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (H93.5) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Health Facilities
Treatment selection for Health Facilities depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Health Facilities)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Check Your Medicine Cabinet: FDA Enforcement Recall D-0042-2027 (Class II): Metoclopramide Tablets, USP, 5 mg, 100 Ta Reason for Recall (Class II): Presence of Foreign Tablets/Capsules openFDA Drug Enforcement & Recall Registry • 2026-10-21 • FDA Drug Recall (Class II) | Multi-cohort | 96/100 | PMID FDARECALL-D-0042-2027 ↗ |
| New Insights on Immunogenicity and safety of a quadrivalent high-dose inactivated influenza: What a 1,528-Participant Study Found IIV4-HD provided superior immunogenicity versus IIV4-SD and was well tolerated in adults aged ≥60 y. Human vaccines & immunotherapeutics • 2021-12-02 • Phase III Randomized Trial | N = 1,528 | 96/100 | PMID 34714720 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Immunogenicity, safety, and lot consistency of the anthrax vaccine adsorbed,: What a 3,689-Participant Study Found The study met the pre-defined endpoint criteria, demonstrating protective level of immune response and non-inferiority of CYFENDUS to BioThrax vaccination. Vaccine • 2026-02-06 • Phase III Randomized Trial | N = 3,689 | 96/100 | PMID 41401704 ↗ |
| Check Your Medicine Cabinet: FDA Enforcement Recall D-0006-2027 (Class II): Sterile Lubricant Dry Eye Relief Eye Drop Reason for Recall (Class II): Lack of Assurance of Sterility openFDA Drug Enforcement & Recall Registry • 2026-10-14 • FDA Drug Recall (Class II) | Multi-cohort | 96/100 | PMID FDARECALL-D-0006-2027 ↗ |
Health Facilities Patient Community & “People Like Me” Threads
Filter Health Facilities community threads and patient logs by age, biological sex, dosage, and treatment duration.